A5100664012- Healthcare Systems and Reforms
- Healthcare Policy and Management
- Pharmaceutical Economics and Policy
- Health Systems, Economic Evaluations, Quality of Life
- Cardiac Arrest and Resuscitation
- Chronic Disease Management Strategies
- Economic and Financial Impacts of Cancer
- Global Cancer Incidence and Screening
- Global Maternal and Child Health
- Sepsis Diagnosis and Treatment
- Traditional Chinese Medicine Analysis
- Disaster Response and Management
- Central Venous Catheters and Hemodialysis
- Pharmacy and Medical Practices
- Plant-based Medicinal Research
- Global Health Care Issues
- Traditional Chinese Medicine Studies
- Emergency and Acute Care Studies
- Primary Care and Health Outcomes
- Migration, Health and Trauma
Union Hospital
2024
Huazhong University of Science and Technology
2024
National Institutes of Pharmaceutical Research and Development (China)
2021-2023
Beijing University of Chinese Medicine
2012-2022
Monash Institute of Medical Research
2009
Monash University
2009
Abstract Background Cancer is a major public health issue worldwide. The cost of cancer care imposes substantial economic burden on society and patient, but it has not been thoroughly studied in China. This study aimed to describe direct elements all types by different beneficial characteristics. Methods research was retrospective observational based inpatient outpatient records with primary diagnosis from 31 hospitals 2016. Total per time were analyzed type, sources (prescription medicines,...
To analyse the changes in curative care expenditure (CCE) associated with noncommunicable diseases (NCDs) before and after Beijing healthcare reform, thus providing a reference for system.A total of 60 medical institutions were selected using multistage stratified cluster random sampling Beijing, China. The records approximately 100 million outpatients NCDs 2016-2018 extracted. System Health Accounts 2011 (SHA2011) was used to estimate CCE. segmented regression model established observe both...
China's health system is challenged by complex problems experienced different population groups and caused multiple diseases. This study examined the distribution of curative care expenditure (CCE) medical institutions in Beijing using beneficiary characteristics such as residency, gender, age, disease. Suggestions are presented for development policies.A total 81 with approximately 80 million patients Beijing, China, were selected via a multistage stratified cluster random sampling...
Objectives To curb the unreasonable growth of medical expenses and reduce burden treatment, Beijing launched two rounds comprehensive reform public hospitals. In reforms, addition drugs consumables was canceled successively. This study compared changes in direct cost inpatients with coronary heart disease (CHD) three stages hospital reforms provides data support for health policies. Setting CHD diagnosis treatment were extracted from Hospital Information System (HIS) 33 The total amount...
The replacement intervals for infusion sets may differ among healthcare institutions, which have an impact on the occurrence of central line-associated bloodstream infections (CLABSI). Nevertheless, there exists a limited amount high-quality evidence available to assist clinicians in determining most suitable sets. Therefore, objective this trial is compare efficacy 24-h and 96-h CLABSI critically ill adults who venous access devices. This multicenter, parallel-group randomized controlled...
Background: Danhong injection (DHI) accounts for the highest proportion of drug costs inpatients with coronary heart disease (CHD). However, if DHI price influences utilization remains unclear. Objective: The objective was to compare changes in use CHD patients during three stages after two comprehensive reforms public hospitals Beijing. These findings will provide support controlling burden and regulating behavior. Research Design: diagnosis treatment data were extracted from Hospital...